Overview

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures

Status:
Terminated
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, and efficacy of AQUAVAN® Injection when used for mild-to-moderate sedation in patients undergoing minor surgical procedures.
Phase:
Phase 3
Details
Lead Sponsor:
Eisai Inc.
Collaborators:
Covance
PPD
Treatments:
Fospropofol
Midazolam